SCHEMBL1161208

SCHEMBL1161208

NN=Cc1c(F)cc(F)cc1F

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
GRIN2B Q13224 2/20 0.35
GRIN2C Q14957 2/20 0.35
GRIN3A Q8TCU5 2/20 0.35
ALDH1A1 P00352 1/20 0.33
ERN1 O75460 1/20 0.32
PTP4A3 O75365 1/20 0.32
MAOB P27338 1/20 0.31
CES2 O00748 1/20 0.30
CES1 P23141 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1161207 1.00 GRIN2D (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL28403114 0.77 ACHE (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30995251 0.77 ACHE (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22176803 0.77 ERN1 (0.31) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL31539751 0.77 CES2 (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL19439647 0.75 CA12 (0.36) ERN1PTP4A3
Hydrochloric Acid SCHEMBL28407167 0.75 ACHE (0.37) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL17712851 0.72 GRIN2D (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL616031 0.72 GAA (0.33) ALDH1A1
SCHEMBL616030 0.72 GAA (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462143-A1 3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES AS C-MET TYROSINE KINASE MODULATORS Novartis AG (CH) 2012-06-13 EP disclosed
WO-2011015652-A1 3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES AS C-MET TYROSINE KINASE MODULATORS NOVARTIS AG (CH) 2011-02-10 WO disclosed